Type 2 airway inflammation in COPD
European Respiratory Journal · 2024-05 · 63 (5) · 2400150
DOI: 10.1183/13993003.00150-2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Respiratory Journal, online erschienen am 14.03.2024. Verfasst von Francesca Polverino und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Inflammation. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Themen: COPD
Abstract (Originalsprache)
Globally, nearly 400 million persons have COPD, and COPD is one of the leading causes of hospitalisation and mortality across the world. While it has been long-recognised that COPD is an inflammatory lung disease, dissimilar to asthma, type 2 inflammation was thought to play a minor role. However, recent studies suggest that in approximately one third of patients with COPD, type 2 inflammation may be an important driver of disease and a potential therapeutic target. Importantly, the immune cells and molecules involved in COPD-related type 2 immunity may be significantly different from those observed in severe asthma. Here, we identify the important molecules and effector immune cells involved in type 2 airway inflammation in COPD, discuss the recent therapeutic trial results of biologicals that have targeted these pathways and explore the future of therapeutic development of type 2 immune modulators in COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
- Centre for Heart Lung Innovation, St. Paul's Hospital and University of British Columbia Division of Respiratory Medicine, Vancouver, BC, Canada Don.Sin@hli.ubc.ca.
Zitieren
APA
Polverino, F., & Sin, D. D. (2024). Type 2 airway inflammation in COPD. European Respiratory Journal, 63(5), 2400150. https://doi.org/10.1183/13993003.00150-2024
Vancouver
Polverino F, Sin DD. Type 2 airway inflammation in COPD. European Respiratory Journal. 2024;63(5):2400150. doi:10.1183/13993003.00150-2024
BibTeX
@article{Polverino2024,
author = {Polverino, Francesca and Sin, Don D},
title = {Type 2 airway inflammation in COPD},
journal = {European Respiratory Journal},
year = {2024},
volume = {63},
number = {5},
pages = {2400150},
doi = {10.1183/13993003.00150-2024}
}
EUVIMED